| BID | 2.57 | ASK | 2.62 | ||
| Open | 2.59 | Previous Close | 2.60 | ||
| Pre-Market | - | After-Market | 2.57 | ||
| - - | -0.02 -0.71% |
| Target Price | 10.50 | Analyst Rating | — 0.00 | |
| Potential % | 305.41 | Finscreener Ranking | ☆ 33.12 | |
| Insiders Trans % 3/6/12 mo. | -/-100/-100 | Value Ranking | ☆ 23.53 | |
| Insiders Value % 3/6/12 mo. | -/-100/-100 | Growth Ranking | ☆ 21.16 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-100/-100 | Income Ranking | — - | |
| Price Range Ratio 52W % | 7.34 | Earnings Rating | — | |
| Market Cap | 53.77M | Earnings Date | 9th Nov 2023 | |
| Alpha | -0.09 | Standard Deviation | 0.38 | |
| Beta | 1.50 |
Today's Price Range 2.572.62 | 52W Range 1.4716.80 |
Summary:
Neutral
| Technical Indicators: | Neutral |
| Moving Averages: | Buy |
| Performance | |||
|---|---|---|---|
| 1 Week | 1.41% | ||
| 1 Month | 0.00% | ||
| 3 Months | -6.83% | ||
| 6 Months | -45.24% | ||
| 1 Year | 386.16% | ||
| 3 Years | -94.83% | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | 418.16 | |||
ROE last 12 Months | -480.62 | |||
ROA (5Y Avg) | -25.85 | |||
ROA last 12 Months | -100.31 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -143.91 | |||
Return on invested Capital Q | -35.29 | |||
Return on invested Capital Y | -103.86 | |||
Assets Turnover | 0.10 | |||
Receivables Turnover | 1.00 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -0.20 | ||||
| 1.97 | ||||
| 10.71 | ||||
| - | ||||
| -2.50 | ||||
| -3.60 | ||||
| -6.58 | ||||
| -0.09 | ||||
| 296.34M | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.60 | ||||
| 0.70 | ||||
| 0.36 | ||||
| 9.52 | ||||
| -193.40 | ||||
| Leverage Ratio | 24.40 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 30.60 | ||||
| -460.60 | ||||
| -444.70 | ||||
| -232.70 | ||||
| -84.44 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 24.33M | ||||
| 0.06 | ||||
| -8.81 | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q02 2023 | -0.97 | -1.08 | -11.34 |
| Q01 2023 | -1.90 | -0.90 | 52.63 |
| Q04 2022 | - | -4.18 | - |
| Q03 2022 | -10.20 | -24.20 | -137.25 |
| Q02 2022 | -4.60 | -15.60 | -239.13 |
| Q01 2022 | - | -15.60 | - |
| Q02 2021 | -0.39 | -0.50 | -28.21 |
| Q01 2021 | -0.27 | -0.22 | 18.52 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | - |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 26.74K |
| Shares Outstanding | 20.76K |
| Shares Float | 3.82M |
| Trades Count | 185 |
| Dollar Volume | 69.61K |
| Avg. Volume | 143.17K |
| Avg. Weekly Volume | 96.91K |
| Avg. Monthly Volume | 236.07K |
| Avg. Quarterly Volume | 96.53K |
Eargo Inc. (NASDAQ: EAR) stock closed at 2.59 per share at the end of the most recent trading day (a -0.38% change compared to the prior day closing price) with a volume of 26.74K shares and market capitalization of 53.77M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 184 people. Eargo Inc. CEO is Christian Gormsen.
The one-year performance of Eargo Inc. stock is 386.16%, while year-to-date (YTD) performance is 350.43%. EAR stock has a five-year performance of %. Its 52-week range is between 1.465 and 16.8, which gives EAR stock a 52-week price range ratio of 7.34%
Eargo Inc. currently has a PE ratio of -0.20, a price-to-book (PB) ratio of 1.97, a price-to-sale (PS) ratio of 10.71, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -100.31%, a ROC of -143.91% and a ROE of -480.62%. The company’s profit margin is -84.44%, its EBITDA margin is -444.70%, and its revenue ttm is $24.33 Million , which makes it $0.06 revenue per share.
Of the last four earnings reports from Eargo Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Eargo Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Eargo Inc. is — (0), with a target price of $10.5, which is +305.41% compared to the current price. The earnings rating for Eargo Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Eargo Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Eargo Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 19.59, ATR14 : 0.08, CCI20 : 72.69, Chaikin Money Flow : -0.07, MACD : 0.09, Money Flow Index : 19.04, ROC : 0.78, RSI : 62.91, STOCH (14,3) : 66.67, STOCH RSI : 0.46, UO : 51.49, Williams %R : -33.33), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Eargo Inc. in the last 12-months were: Adam Laponis (Sold 21 shares of value $155 ), Brownie William (Sold 29 shares of value $176 ), Christian Gormsen (Sold 64 shares of value $472 ), Gormsen Christian (Sold 122 shares of value $744 ), Laponis Adam (Sold 40 shares of value $244 ), Mark Thorpe (Sold 7 shares of value $44 ), William Brownie (Sold 15 shares of value $111 )
Eargo Inc.
Eargo Inc is a medical device company, focused on improving the quality of life of people with hearing loss. The company offers hearing aids, professional support services, and other insurance-related services. The product portfolio includes Eargo Neo HiFi, Eargo Neo, Eargo Max, and related accessories.
CEO: Christian Gormsen
Telephone: +1 650 351-7700
Address: 1600 Technology Drive, San Jose 95110, CA, US
Number of employees: 184
